R&D Views & Analysis | pharmaphorum

Views & Analysis

Patients

Operationalising diversity through site and patient engageme...

Most sponsors are aware of the benefits that may arise from increasing the diversity of clinical trial patient populations.

R&D

Inside the NCVR evolution in the UK

For years, the UK's clinical research landscape held a frustrating truth: costing and contracting for commercial research needed to evolve if the nation was to remain an attractive option f

R&D

This week in clinical trials: 15th-19th January 2024

Continuing our clinical trials updates of 2024, in this instalment we look back at developments in life sciences research and development announced during the week of 15th to 19th January,

R&D

Brighter times ahead for biotech in 2024?

The biotech industry experienced heady highs in early 2021, but has since suffered from a tight financial climate that has brought bankruptcies and widespread redundancies.

R&D